Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006-2017.
Kamau E. et al, (2021), Emerging infectious diseases, 27, 2261 - 2268
Incidence and risk factors for persistent symptoms in adults previously hospitalised for COVID-19.
Munblit D. et al, (2021), Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children.
Han AX. et al, (2021), eLife, 10
Time to reconsider the role of ribavirin in Lassa fever
Salam AP. et al, (2021), PLOS Neglected Tropical Diseases, 15, e0009522 - e0009522
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group None. et al, (2021), JAMA
Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe-results from the PED-MERMAIDS multicentre case-control study.
Kohns Vasconcelos M. et al, (2021), BMJ open respiratory research, 8
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
Docherty AB. et al, (2021), The Lancet Respiratory Medicine, 9, 773 - 785
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
Drake TM. et al, (2021), The Lancet Rheumatology, 3, e498 - e506
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Abdukahil SA. et al, (2021), Infection
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
Leclerc QJ. et al, (2021), BMC Health Services Research
Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study
Patone M. et al, (2021), The Lancet Infectious Diseases
Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations.
Manoharan L. et al, (2021), Trials, 22
Evaluating clinical characteristics studies produced early in the Covid-19 pandemic: A systematic review
Manoharan L. et al, (2021), PLOS ONE, 16, e0251250 - e0251250
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Abani O. et al, (2021), The Lancet, 397, 2049 - 2059
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2021), The Lancet, 397, 1637 - 1645